Citation 85200

ANKLI,A: HEILMANN,J: HEINRICH,M: STICHER,O:. (2000). CYTOTOXIC CARDENOLIDES AND ANTIBACTERIAL TERPENOIDS FROM CROSSOPETALUM GAUMERI.. 54(5)

Citation Details

Title	CYTOTOXIC CARDENOLIDES AND ANTIBACTERIAL TERPENOIDS FROM CROSSOPETALUM GAUMERI.
Authors	ANKLI,A: HEILMANN,J: HEINRICH,M: STICHER,O:
Year	2000
Volume	54
Issue	5

Summary

Year: 2000

Journal: Unknown

Organisms and Their Experiments (1)

Crossopetalum gaumeri (CELASTRACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIBACTERIAL ACTIVITY	VOUCHER SPECIMEN REPORTED FORPHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
2	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
3	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
4	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	OURATEACATECHIN	None
5	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OURATEACATECHIN	WEAK ACTIVITY
6	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	SECURIGENIN-3-BETA-O-BETA-6-DEOXY-GULOSIDE	None
7	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SECURIGENIN-3-BETA-O-BETA-6-DEOXY-GULOSIDE	ACTIVE
8	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	CANESCEIN	None
9	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CANESCEIN	ACTIVE
10	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	SARMENTOGENIN,19-HYDROXY: 3-BETA-O-BETA-6-DEOXY-GULOSIDE	None
11	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SARMENTOGENIN,19-HYDROXY: 3-BETA-O-BETA-6-DEOXY-GULOSIDE	ACTIVE
12	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	SARMENTOGENIN-3-BETA-O-[ALPHA-ALLOSYL(1-4)-BETA-6-DEOXY-ALLOSIDE]	None
13	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SARMENTOGENIN-3-BETA-O-[ALPHA-ALLOSYL(1-4)-BETA-6-DEOXY-ALLOSIDE]	ACTIVE
14	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	SECURIGENIN-3-BETA-O-[ALPHA-ALLOSYL(1-4)-BETA-6-DEOXY-ALLOSIDE]	None
15	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SECURIGENIN-3-BETA-O-[ALPHA-ALLOSYL(1-4)-BETA-6-DEOXY-ALLOSIDE]	ACTIVE
16	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	ABIETA-3-8-11-13-TETRAENE,18-NOR: 3-15-DIHYDROXY:	None
17	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ABIETA-3-8-11-13-TETRAENE,18-NOR: 3-15-DIHYDROXY:	INACTIVE
18	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ABIETA-3-8-11-13-TETRAENE,18-NOR: 3-15-DIHYDROXY:	EQUIVOCAL
19	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ABIETA-3-8-11-13-TETRAENE,18-NOR: 3-15-DIHYDROXY:FRIEDELAN-3-ON-29-OL	INACTIVE
20	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ABIETA-3-8-11-13-TETRAENE,18-NOR: 3-15-DIHYDROXY:FRIEDELAN-3-ON-29-OL	INACTIVE
21	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	FRIEDELAN-29-OIC ACID,24-NOR: 2-3-7-TRIHYDROXY-6-OXO-1-3-5(10)-7-TETRAENE: METHYL ESTER	None
22	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FRIEDELAN-29-OIC ACID,24-NOR: 2-3-7-TRIHYDROXY-6-OXO-1-3-5(10)-7-TETRAENE: METHYL ESTER	WEAK ACTIVITY
23	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FRIEDELAN-29-OIC ACID,24-NOR: 2-3-7-TRIHYDROXY-6-OXO-1-3-5(10)-7-TETRAENE: METHYL ESTER	WEAK ACTIVITY
24	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FRIEDELAN-29-OIC ACID,24-NOR: 2-3-7-TRIHYDROXY-6-OXO-1-3-5(10)-7-TETRAENE: METHYL ESTER	WEAK ACTIVITY
25	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FRIEDELAN-29-OIC ACID,24-NOR: 2-3-7-TRIHYDROXY-6-OXO-1-3-5(10)-7-TETRAENE: METHYL ESTER	ACTIVE
26	Not specified	ISOLATION AND IDENTIFICATION OF	PRISTIMERINCELASTROLFRIEDELAN-3-ON-29-OL	None
27	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FRIEDELAN-3-ON-29-OL	INACTIVE
28	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FRIEDELAN-3-ON-29-OL	INACTIVE
29	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PRISTIMERIN	ACTIVE
30	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PRISTIMERIN	ACTIVE
31	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PRISTIMERIN	ACTIVE
32	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PRISTIMERIN	ACTIVE
33	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CELASTROL	ACTIVE
34	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CELASTROL	ACTIVE
35	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CELASTROL	ACTIVE
36	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CELASTROL	ACTIVE

Citation 85200

Citation Details

Summary

Organisms and Their Experiments (1)

Crossopetalum gaumeri (CELASTRACEAE)

Show SPARQL Queries (1)

Query 1